188 related articles for article (PubMed ID: 22519427)
21. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
Criado G; Simelyte E; Inglis JJ; Essex D; Williams RO
Arthritis Rheum; 2009 May; 60(5):1342-51. PubMed ID: 19404944
[TBL] [Abstract][Full Text] [Related]
22. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
[TBL] [Abstract][Full Text] [Related]
23. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
25. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
26. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.
Niinisalo P; Oksala N; Levula M; Pelto-Huikko M; Järvinen O; Salenius JP; Kytömäki L; Soini JT; Kähönen M; Laaksonen R; Hurme M; Lehtimäki T
Ann Med; 2010; 42(1):55-63. PubMed ID: 19941414
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer.
Ino K
Curr Opin Obstet Gynecol; 2011 Feb; 23(1):13-8. PubMed ID: 20930628
[TBL] [Abstract][Full Text] [Related]
28. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
29. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2,3-dioxygenase in tumor induced tolerance.
Liu XQ; Wang X
Chin Med J (Engl); 2009 Dec; 122(24):3072-7. PubMed ID: 20137504
[TBL] [Abstract][Full Text] [Related]
31. Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi.
Knubel CP; Martínez FF; Fretes RE; Díaz Lujan C; Theumer MG; Cervi L; Motrán CC
FASEB J; 2010 Aug; 24(8):2689-701. PubMed ID: 20233946
[TBL] [Abstract][Full Text] [Related]
32. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
[TBL] [Abstract][Full Text] [Related]
33. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-dioxygenase in materno-fetal interaction.
Sedlmayr P
Curr Drug Metab; 2007 Apr; 8(3):205-8. PubMed ID: 17430108
[TBL] [Abstract][Full Text] [Related]
35. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
[TBL] [Abstract][Full Text] [Related]
36. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
Pertovaara M; Raitala A; Lehtimäki T; Karhunen PJ; Oja SS; Jylhä M; Hervonen A; Hurme M
Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
Furuzawa-Carballeda J; Lima G; Jakez-Ocampo J; Llorente L
Eur J Clin Invest; 2011 Oct; 41(10):1037-46. PubMed ID: 21366559
[TBL] [Abstract][Full Text] [Related]
38. Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence.
Luukkainen A; Toppila-Salmi S
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):37-44. PubMed ID: 23128419
[TBL] [Abstract][Full Text] [Related]
39. [Preparation of anti-human indoleamine 2,3-dioxygenase polyclonal antibody].
Xie BL; Liu P; Ou XL; Du J
Ai Zheng; 2007 Mar; 26(3):329-32. PubMed ID: 17355802
[TBL] [Abstract][Full Text] [Related]
40. The role of tryptophan catabolism in acquisition and effector function of memory T cells.
Dai H; Dai Z
Curr Opin Organ Transplant; 2008 Feb; 13(1):31-5. PubMed ID: 18660704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
